Celldex Therapeutics | CLDX - Capital Ordinário

Preço das Ações
30.99
Mudança Diária
-0.81 -2.55%
Mensal
0.55%
Anual
53.80%
Q1 Previsão
29.97




Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 35.32M 2.51M 2025-12
Amgen USD 539M 1000K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celldex Therapeutics USD 66.55M 102K 2025-12
Glaxosmithkline GBP 4.08B 49.43M 2025-12
Nektar Therapeutics USD 19K 0 2024-09
Northwest Biotherapeutics USD 1.14M 30K 2023-09
Pfizer USD 5.69B 1000K 2025-09
Rigel Pharmaceuticals USD 17K 158K 2024-06
Roche Holding CHF 795.62M 699.54K 2025-12